The global blood group typing market is witnessing steady growth as healthcare providers place greater emphasis on blood transfusion safety, accurate diagnosis, and improved patient care. Increasing demand for blood components, rising surgical procedures, and the growing prevalence of chronic diseases are supporting the adoption of advanced blood grouping technologies across hospitals, diagnostic laboratories, and blood banks. Technological advancements in automated testing systems and molecular diagnostic methods are also improving the accuracy, speed, and efficiency of blood group identification.

According to Straits Research, the global blood group typing market size was valued at USD 2.08 billion in 2025 and is projected to grow from USD 2.27 billion in 2026 to USD 4.55 billion by 2034, registering a CAGR of 9.1% during the forecast period from 2026 to 2034. North America dominated the market with a revenue share of 38.4% in 2025.

Key Market Insights

  • Market Size (2025): USD 2.08 billion
  • Market Size (2026): USD 2.27 billion
  • CAGR (Forecast Period): 9.1% from 2026 to 2034
  • Forecast Year: 2034
  • Projected Market Size (2034): USD 4.55 billion
  • Dominant Region: North America
  • North America Market Share (2025): 38.4%

Blood Group Typing Market Overview

The market is expanding alongside improvements in healthcare infrastructure, increasing investments in diagnostic technologies, and the growing importance of transfusion safety. Healthcare facilities are increasingly adopting advanced testing solutions to minimize compatibility errors and improve laboratory efficiency.

Blood Group Typing Market Growth Drivers

Increasing Number of Blood Donations and Transfusions

The rising number of voluntary blood donations is creating consistent demand for blood group typing products and services. Blood banks and healthcare facilities require accurate blood classification to ensure the safety of collected blood and maintain sufficient supplies for patients. The growing need for transfusions during emergency treatments, surgeries, and chronic disease management is further supporting market expansion.

Growing Prevalence of Chronic Diseases and Blood Disorders

The increasing incidence of cancer, sickle cell disease, thalassemia, and other blood-related disorders is contributing to the demand for regular blood transfusions. Patients undergoing chemotherapy and long-term treatment frequently require compatible blood components. Consequently, healthcare providers are strengthening blood screening and typing procedures to improve patient safety and treatment outcomes.

Blood Group Typing Market Challenges

Shortage of Skilled Laboratory Professionals

The limited availability of trained medical laboratory professionals remains a significant challenge, particularly across developing healthcare markets. Blood group typing requires qualified personnel to operate diagnostic equipment, interpret results, and maintain testing accuracy. Workforce shortages can increase laboratory turnaround times and restrict the adoption of advanced testing solutions.

Limited Healthcare Infrastructure in Emerging Economies

Uneven access to advanced diagnostic facilities and reliable blood banking infrastructure can affect market penetration in developing regions. Inadequate laboratory resources and limited awareness of transfusion safety procedures may also slow the adoption of modern blood group typing technologies.

Blood Group Typing Market Opportunities

Expansion of Healthcare Infrastructure in Emerging Economies

Increasing investments in hospitals, diagnostic laboratories, and blood banking facilities across emerging economies are creating new opportunities for market participants. Countries such as India and China are strengthening their healthcare infrastructure to address growing patient populations and improve access to diagnostic services. These developments are expected to support demand for blood grouping instruments, reagents, and testing solutions.

Increasing Demand for Automated Laboratory Solutions

The growing need to improve laboratory productivity and reduce manual testing errors is encouraging healthcare facilities to adopt automated blood grouping systems. Automation can support standardized testing procedures, faster result processing, and efficient management of higher sample volumes.

Blood Group Typing Market Segment Analysis

The global blood group typing market is segmented by techniques, test type, product type, and end-user.

By Techniques

  • PCR-Based and Microarray Technique
  • Massively Parallel Sequencing
  • Assay-Based Techniques
  • Others
    Antibody screening represents an important segment because of its role in identifying unexpected antibodies that may cause adverse transfusion reactions. The procedure is also widely used during pregnancy and before surgical interventions to assess potential blood compatibility risks. Increasing emphasis on pre-transfusion screening is supporting demand for these tests.

By Product Type

  • Instruments
  • Services
  • Consumables

The consumables segment accounts for a significant share of the market due to the recurring requirement for reagents and testing materials. Antisera reagents, red blood cell reagents, anti-human globulin reagents, and other laboratory supplies are essential for routine blood typing procedures. Increasing blood donations and transfusion activities are generating consistent demand for these products.

By End-User

  • Clinical Laboratories
  • Blood Banks
  • Hospitals
  • Others

Blood Group Typing Market Regional Analysis

North America Dominates the Global Market

The presence of established diagnostic technology manufacturers and continued investments in healthcare research are further strengthening the region’s market position. The United States and Canada remain important markets due to their developed healthcare systems and emphasis on transfusion safety.

Middle East, Africa, and Latin America Show Emerging Potential

The Middle East, Africa, and Latin America are witnessing gradual improvements in healthcare infrastructure and diagnostic capabilities. Government initiatives to strengthen blood donation programs and improve access to healthcare services are creating opportunities for market expansion. However, differences in healthcare spending, laboratory infrastructure, and access to trained professionals continue to influence regional adoption.

Competitive Landscape of the Blood Group Typing Market

Companies are also focusing on expanding their product portfolios and improving diagnostic accuracy to address the growing requirements of hospitals, blood banks, and clinical laboratories.

List of Key Companies in the Blood Group Typing Market

  • Quotient Limited
  • Immucor Inc.
  • Merck KGaA
  • DIAGAST
  • The Novacyt Group
  • Agena Bioscience Inc.
  • BAG Diagnostics GmbH
  • AXO Science
  • Grifols S.A.
  • Rapid Labs Limited

Recent Developments in the Blood Group Typing Market

Product innovation and the expansion of blood screening capabilities remain important areas of development in the market.

  • July 2022: Quotient Limited entered into an agreement with InfYnity Biomarkers to expand the infectious disease testing menu available through its MosaiQ platform. The development reflected the industry’s focus on expanding automated blood screening capabilities.
  • Future Outlook of the Blood Group Typing Market

The global blood group typing market is expected to experience sustained growth through 2034, supported by increasing blood transfusion requirements, rising chronic disease prevalence, and improvements in diagnostic technologies. The growing emphasis on transfusion compatibility and patient safety will continue to encourage healthcare providers to invest in reliable blood typing solutions.

Click Here to Access the Comprehensive Report : https://straitsresearch.com/report/blood-group-typing-market

About Straits Research

Straits Research is a global market intelligence and consulting company that provides comprehensive market research reports, industry analysis, and strategic insights across various industries. The company delivers data-driven research and actionable intelligence to help businesses understand market dynamics, identify emerging opportunities, evaluate competitive landscapes, and make informed strategic decisions. Through its research capabilities and industry expertise, Straits Research supports organizations in navigating evolving markets and achieving sustainable business growth.

Leave a Reply